Petition For Post-Grant Review Of Fusion Protein Patent Filed With Board

(September 9, 2021, 10:44 AM EDT) -- ALEXANDRIA, Va. — A recently issued patent claiming formulations that comprise a vascular endothelial growth factor (VEGF) antagonist fusion protein suffers from inadequate written description or, alternatively, would have been obvious...
To view the full article, register now.